Impact of volume of irradiation on survival and quality of life in glioblastoma: a prospective, phase 2, randomized comparison of RTOG and MDACC protocols.

Narendra KumarRidu KumarSuresh C SharmaAnindya MukherjeeNiranjan KhandelwalManjul TripathiRaviteja MiriyalaArun S OinamRenu MadanBudhi S YadavDivya KhoslaRakesh Kapoor

Published in: Neuro-oncology practice (2019)

Use of limited-margin MDACC protocol can potentially improve survival outcomes apart from QoL of glioblastoma patients, as compared with the RTOG protocol.

Keyphrases

end stage renal disease
randomized controlled trial
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
clinical trial
radiation therapy
phase iii